405 filings
Page 3 of 21
6-K
y7zodxe
28 Feb 23
Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
6:00am
6-K
mt0dm4
24 Feb 23
Galapagos announces full year 2022 results and outlook for 2023
8:13am
6-K
52czng2gnoodx
10 Feb 23
Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
6:29am
6-K
cuf q9yij
8 Feb 23
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
4:53pm
6-K
lur6gskcb b88my5qw
19 Jan 23
Current report (foreign)
8:26am
6-K
mrzen oxmbs1ni33jm
10 Jan 23
Galapagos receives transparency notification from FMR LLC
4:32pm
6-K
bwmnkj1jsq qum
5 Jan 23
Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference
6:14am
6-K
uangv 165
5 Jan 23
Galapagos receives transparency notification from FMR LLC
6:05am
6-K
4ae2lv4
23 Dec 22
Galapagos announces changes to Executive Committee
6:05am
6-K
oegk0 nv8qkgey
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
S-8
o2lqxylsg
12 Dec 22
Registration of securities for employees
4:08pm
6-K
4utt46xz 4w
14 Nov 22
Current report (foreign)
6:05am
6-K
g1tfwg6gvt32sqk5 qi
9 Nov 22
Current report (foreign)
4:05pm
6-K
4lgxiy05ugwju4l
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
naba nkgt9l16zq0qatf
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
sdb2j2
17 Oct 22
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
6:05am
6-K
03d6y5jz
6 Oct 22
Current report (foreign)
5:11pm
6-K
pma2xuec5tj3
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
kd22q0kxqni24o
27 Sep 22
Current report (foreign)
5:03pm
6-K
yns9t7mipe
30 Aug 22
Galapagos receives transparency notification from FMR LLC
6:00am